Keywords: bayer/fournier, market, cerivastatin, europe, cholesterol-lowering, drug, co-marketed

Bayer/Fournier Market Cerivastatin In Europe

Article | 01 September 1998

The cholesterol-lowering drug cerivastatin is to be co-marketed inseveral European countries by Bayer AG, which developed the drug, and Laboratoires ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Baycol

Cerivastatin

Aspirin

Bayer

Go to drug listing